Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BMS-813160 by Bristol-Myers Squibb for Non-Small Cell Lung Cancer: Likelihood of Approval
BMS-813160 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Non-Small Cell Lung Cancer. According to...
BMS-813160 by Bristol-Myers Squibb for Hepatocellular Carcinoma: Likelihood of Approval
BMS-813160 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData, Phase...
BMS-813160 by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval
BMS-813160 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Solid Tumor. According to GlobalData, Phase...